UVAX-1107

N/A

Report date: 2024/08/13 16:50:18

Base Information

Drug NameUVAX-1107
Drug Alias NameUVAX-1107
ClassificationVaccines > Development/production technology > Synthetic peptide vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsLymphoma, AIDS-RelatedVaccine-Preventable DiseasesHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesThe Scripps Research Institute IncUvax Bio LLC
China Registration ClassN/A

Develop Information

Active CompaniesUvax Bio LLC
Inactive CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsLymphoma, AIDS-RelatedVaccine-Preventable DiseasesHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A